[1]
Izquierdo, G. 2026. Use of nirsevimab in extremely preterm infants: position of the Neonatal Infections Committee of the Chilean Society of Infectious Diseases. Revista Chilena de Infectología. 43, 4 (Jun. 2026). DOI:https://doi.org/10.4067/s0716-10182026000400151.